LifeScience Clinical & Diagnostic
Telix Resubmits US NDA For Pixclara PET Imaging Agent Targeting Glioma Diagnosis
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food ...
March 17, 2026 | News
Akeso Secures China IND Clearance For First In Class Trispecific Antibody AK150 Targeting Solid Tumours
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has rec...
March 17, 2026 | News
Vimgreen Pharmaceuticals Secures China IND Approval For VG081821 In NASH Clinical Development
Vimgreen Pharmaceuticals, a leading innovator in adenosine signaling modulation, announced the approval of its Investigational New Drug (IND) application f...
March 16, 2026 | News
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility...
March 13, 2026 | News
Meiji Seika Pharma Initiates Phase I Trial Of ME3241 PD 1 Agonist Antibody For Autoimmune Diseases
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced that it has in...
March 12, 2026 | News
Everest Medicines Launches VELSIPITY Oral Therapy For Ulcerative Colitis In Mainland China
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
March 11, 2026 | News
Codex Genetics And C2N Diagnostics Partner To Expand Alzheimer’s Blood Test Access In Hong Kong
Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a...
March 11, 2026 | News
Leads Biolabs Doses First Patient In Phase II Trial Of PD L1 4 1BB Bispecific Antibody For Esophageal Cancer
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced on March 6, 2026 that the first patient has bee...
March 10, 2026 | News
China Approves Sciwind Ecnoglutide Injection For Chronic Weight Management
Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabo...
March 09, 2026 | News
Thermo Fisher Opens Advanced Distribution And Labelling Centre In Uppsala To Strengthen Global Immunodiagnostics Supply
Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of a new 8,000-square-meter distribution and labeling center supp...
March 05, 2026 | News
XellSmart Secures Fourth Dual US And China Regulatory Clearance For iPSC Derived Cell Therapy In Multiple System Atrophy
XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for P...
March 04, 2026 | News
Ono Pharmaceutical And Congruence Expand Research Alliance Into Neurology And Immunology
Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candi...
March 04, 2026 | News
Hua Medicine Secures First Glucokinase Activator Approval Outside Mainland China In Hong Kong
First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to Type 2 diabetes (T2D) ma...
March 04, 2026 | News
Thermo Fisher Launches TacroType Pharmacogenetic Test To Personalise Tacrolimus Dosing In Transplant Care
TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ ...
March 03, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
